Webinars, Pharmaceutical

Understanding the Evolution of Intranasal Vaccines

Intranasal vaccination is an interesting and increasingly attractive alternative to improving the delivery of therapeutic vaccines. It comes with the promise of better efficacy by stimulating local mucosal response, needle-free delivery and could be self-administrable. These qualities present several opportunities for future immunizations but there are still several challenges to overcome in their development and future commercialization.

In this webinar, we review and share insights on success factors in developing an intranasal vaccine, and provide an overview of intranasal formulations and formulation strategies for both liquid and powder administration. We also assess the available options for intranasal device platforms, review nasal deposition models and discuss the latest intranasal vaccine manufacturing needs from development to commercial scale.

Watch the webinar on Understanding the Evolution of Intranasal Vaccines
Speaker(s): Nektaria Karavas Julie D. Suman
9 Nov 2022

Learn more about Aptar Pharma Expertise
in Nasal Vaccines

Find Out More About Nasal Vaccines

This Might Also Be of Interest

9 Nov 2022

Understanding the Evolution of Intranasal Vaccines

Webinars, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
7 Nov 2022

Intranasal Delivery of Vaccines Using Thin Film Freeze-Dried Powd...

Publications, Pharmaceutical, Device Innovations, Market Insights, Product Solutions

Read More
12 Jul 2022

Nasal Drug Delivery: Beyond Hayfever

Webinars, Pharmaceutical, Innovation & Insights, Market Insights, Product Solutions

Read More
25 Apr 2022

Nasal Drug Development, Trends and Challenges with Nasal Formulat...

Publications, Pharmaceutical, Device Innovations, Brand Differentiation, Market Insights, Product Solutions

Read More
1 2 3

Request Access

Close

Requesting access to Understanding the Evolution of Intranasal Vaccines.

  • This field is for validation purposes and should be left unchanged.
Back To Top